ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

Burzynski, Monaco Clashed In Court

June 5, 1992

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

AACI, SCO, ACCC Hold Meeting With HCFA On DRG Issue

June 17, 1983

Cancer Mmeetings Lister For Next Three Months

February 23, 1996